It's pretty clear that the persistent seller in the high 1.40s/ low 1.50s has not completely sold down yet. It will only break above 1.60 once that seller runs out. Of course I'm assuming it is only one larger holder that is constantly selling into strength.
FDA approval is looking like at least another 12 months as 1 of the 3 required trial sites is only just beginning. Not good news for the next 12 months.
I think they are relying too heavily on the 'potential takeover' angle. The market is calling BS on it.
- Forums
- ASX - By Stock
- Ann: Quarterly update and Appendix 4C
GSS
genetic signatures limited
Add to My Watchlist
2.67%
!
36.5¢

It's pretty clear that the persistent seller in the high 1.40s/...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
36.5¢ |
Change
-0.010(2.67%) |
Mkt cap ! $82.90M |
Open | High | Low | Value | Volume |
36.5¢ | 36.5¢ | 36.5¢ | $160 | 438 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 19601 | 36.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 32411 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 14601 | 0.365 |
2 | 9513 | 0.360 |
3 | 30509 | 0.350 |
1 | 1683 | 0.300 |
1 | 25000 | 0.270 |
Price($) | Vol. | No. |
---|---|---|
0.375 | 32411 | 1 |
0.380 | 3086 | 1 |
0.390 | 20000 | 1 |
0.395 | 5000 | 1 |
0.400 | 111918 | 2 |
Last trade - 13.38pm 04/07/2025 (20 minute delay) ? |
Featured News
GSS (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online